LifeStance Health (LFST) Fundamental Analysis: Revenue, Earnings & Valuation

7.81 / 10

Outperform

Fundamentally the stock scores 7.8/10, rated Outperform. Strong operating cash‑flow growth, robust asset‑to‑market and revenue‑to‑market ratios, and high EPS growth drive optimism. However PB‑ROE and cash‑to‑market metrics lag, tempering the bullish outlook.

Analysis Checks(6/10)

Revenue-MV

Value0.14

Score3/3

Weight23.69%

1M Return7.98%

Net cash flow from operating activities per share (YoY growth rate %)

Value34.30

Score1/3

Weight2.14%

1M Return0.81%

PB-ROE

Value0.16

Score1/3

Weight-0.92%

1M Return-0.34%

Basic earnings per share (YoY growth rate %)

Value120.00

Score3/3

Weight13.59%

1M Return4.72%

Total profit (YoY growth rate %)

Value121.46

Score3/3

Weight14.63%

1M Return5.14%

Net cash flow from operating activities (YoY growth rate %)

Value36.26

Score2/3

Weight4.16%

1M Return1.55%

Cash-UP

Value0.44

Score1/3

Weight1.70%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value113.33

Score3/3

Weight14.42%

1M Return5.00%

Asset-MV

Value-0.55

Score3/3

Weight30.09%

1M Return9.13%

Cash-MV

Value-0.29

Score0/3

Weight-3.51%

1M Return-1.72%

Is LFST undervalued or overvalued?

LFST scores 7.81/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.65% ROE, 0.68% net margin, 252.72 P/E ratio, 1.61 P/B ratio, and 120.00% earnings growth, these metrics solidify its Outperform investment rating.